Polar Asset Management Partners’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,165,086
| Closed | -$30.2K | – | 896 |
|
|
2024
Q3 | $30.2K | Hold |
2,165,086
| – | – | ﹤0.01% | 560 |
|
|
2024
Q2 | $75.7K | Hold |
2,165,086
| – | – | ﹤0.01% | 486 |
|
|
2024
Q1 | $119K | Hold |
2,165,086
| – | – | ﹤0.01% | 494 |
|
|
2023
Q4 | $140K | Hold |
2,165,086
| – | – | ﹤0.01% | 469 |
|
|
2023
Q3 | $509K | Hold |
2,165,086
| – | – | 0.01% | 477 |
|
|
2023
Q2 | $258K | Hold |
2,165,086
| – | – | ﹤0.01% | 569 |
|
|
2023
Q1 | $88.8K | Hold |
2,165,086
| – | – | ﹤0.01% | 656 |
|
|
2022
Q4 | $108K | Hold |
2,165,086
| – | – | ﹤0.01% | 750 |
|
|
2022
Q3 | $123K | Hold |
2,165,086
| – | – | ﹤0.01% | 828 |
|
|
2022
Q2 | $195K | Buy |
2,165,086
+1,422,523
| +192% | +$128K | ﹤0.01% | 787 |
|
|
2022
Q1 | $267K | Hold |
742,563
| – | – | ﹤0.01% | 711 |
|
|
2021
Q4 | $371K | Buy |
+742,563
| New | +$371K | ﹤0.01% | 862 |
|